Sangamo Therapeutics, Inc. removed
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.589 USD | +4.92% | +13.16% | +9.66% |
May. 09 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.66% | 116M | |
+5.06% | 109B | |
+11.62% | 105B | |
-0.17% | 22.25B | |
-11.92% | 22.09B | |
-7.91% | 18.68B | |
-38.36% | 17.58B | |
-9.95% | 16.85B | |
+4.50% | 13.76B | |
+36.51% | 12.46B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Sangamo Therapeutics, Inc.(NasdaqGS: SGMO) dropped from NASDAQ Biotechnology Index